HSR26-239: Outcomes in Multiple Myeloma Hospitalizations With CAR-T Therapies in the United States.

Authors

• Kuldeepsinh Atodaria, Department of Medicine, Division of Hematology & Oncology, Reading Hospital - Tower Health, West Reading, PA, USAFollow
• Pratap Tetali, Department of Medicine, Division of Hematology & Oncology, Reading Hospital - Tower Health, West Reading, PA, USAFollow
• Niharika Kottapalli, Department of Medicine, Division of Hematology & Oncology, Reading Hospital - Tower Health, West Reading, PA, USAFollow
• Sabah Iqbal, Department of Medicine, Division of Hematology & Oncology, Reading Hospital - Tower Health, West Reading, PA, USAFollow
• Shobha Mandal, Department of Medicine, Division of Hematology & Oncology, Reading Hospital - Tower Health, West Reading, PA, USAFollow
• Raza Zarrar, Department of Medicine, Division of Hematology & Oncology, Reading Hospital - Tower Health, West Reading, PA, USAFollow
• Ammar Ashfaq

Document Type

Article

Publication Date

3-31-2026

Publication Title

J Natl Compr Canc Netw

Volume

24

Issue

3.5

Recommended Citation

Atodaria, K., Tetali, P., Kottapalli, N., Iqbal, S., Mandal, S., Zarrar, R., & Ashfaq, A. (2026). HSR26-239: Outcomes in Multiple Myeloma Hospitalizations With CAR-T Therapies in the United States.. J Natl Compr Canc Netw, 24 (3.5) https://doi.org/https://doi.org/10.6004/jnccn.2025.7311